GLP-3 (RT)
A synthetic triple receptor agonist targeting GLP-1, GIP, and glucagon pathways. Studied in clinical models for its effects on metabolic regulation and weight management. 10mg | Premium Research Peptide.
GLP-3 (RT) | 10mg | Research Peptide
GLP-3 (RT) is a synthetic peptide and next-generation triple receptor agonist, meaning it targets three separate hormone receptors at once — GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon. Most well-known research peptides in this class only target one or two receptors, making GLP-3 (RT) one of the more advanced compounds currently being studied in metabolic research.
Each vial contains 10mg of GLP-3 (RT) in lyophilized (freeze-dried powder) form, ready to be reconstituted with bacteriostatic water before use in a research setting.
What the specs mean:
- 10mg per vial — the total amount of peptide in each vial
- Triple agonist — simultaneously activates GLP-1, GIP, and glucagon receptors, each playing a distinct role in energy balance and metabolic function
- Lyophilized powder — freeze-dried for stability and longer shelf life; needs to be mixed with liquid before use
- ≥99% purity (HPLC verified) — independently tested to confirm minimal impurities
- Storage: 2-8°C — keep refrigerated and out of direct light to maintain potency
For research purposes only. Not intended for human or veterinary use. Not for therapeutic, diagnostic, or drug use.
